Première partie : analyse descriptive de l'activité « Mesure continue du, p.23 ,
Analyse descriptive de l'activité « Mesure Continue du Glucose, p.26 ,
46 3. Temps d'utilisation et pourcentage d'abandon, p.47 ,
Department of Pediatrics ,
MD (I) ,
); (3) Nemours Children's Clinic, C ,
MD (I) ,
Department of Pediatrics ,
MD (I) ,
The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N. Engl. J. Med, vol.1, issue.329, pp.977-986, 1993. ,
Realistic Expectations and Practical Use of Continuous Glucose Monitoring for the Endocrinologist, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.7, pp.2232-2238, 2009. ,
DOI : 10.1210/jc.2008-2625
Pompes à insuline et capteurs de glucose interstitiel, pp.25-35, 2012. ,
Continuous Glucose Monitoring: Real-Time Algorithms for Calibration, Filtering, and Alarms, Journal of Diabetes Science and Technology, vol.4, issue.2, pp.404-418, 2010. ,
DOI : 10.1177/193229681000400222
Technologies for Continuous Glucose Monitoring: Current Problems and Future Promises, Journal of Diabetes Science and Technology, vol.24, issue.9, pp.1540-1562, 2010. ,
DOI : 10.1016/0956-5663(92)85053-D
Usage and Effectiveness of the Low Glucose Suspend Feature of the Medtronic Paradigm Veo Insulin Pump, Journal of Diabetes Science and Technology, vol.11, issue.4, pp.1137-1141, 2011. ,
DOI : 10.1089/dia.2008.0032
La mesure en continu du glucose : Quel impact sur l'équilibre glycémique? Quelles indications? Comment l'utiliser en pratique?, pp.107-122 ,
Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness, pp.1-309, 2012. ,
Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring, Diabetes Care, vol.29, issue.12, pp.2730-2732, 2006. ,
DOI : 10.2337/dc06-1134
Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial, Diabetologia, vol.114, issue.7, pp.1250-1257, 2009. ,
DOI : 10.1007/s00125-009-1365-0
Continuous glucose monitoring and intensive treatment of type 1 diabetes, N. Engl. J. Med, vol.359, pp.1464-1476, 2008. ,
Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes, Diabetes Care, vol.34, issue.4 ,
DOI : 10.2337/dc10-1989
Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type???1 diabetes; a randomized controlled trial, Diabetic Medicine, vol.26, issue.10, pp.1158-1167, 2011. ,
DOI : 10.1111/j.1464-5491.2011.03256.x
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes, New England Journal of Medicine, vol.363, issue.4, pp.311-320, 2010. ,
DOI : 10.1056/NEJMoa1002853
Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens: A 1-year multicenter study, Diabetes Care, vol.35, issue.5, pp.965-971, 2012. ,
DOI : 10.2337/dc11-2021
Should minimal blood glucose variability become the gold standard of glycemic control?, Journal of Diabetes and its Complications, vol.19, issue.3, pp.178-181, 2005. ,
DOI : 10.1016/j.jdiacomp.2004.10.001
Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia: Reduction in nocturnal hypoglycemia in those at greatest risk, Diabetes Care, vol.34, issue.9, pp.2023-2025, 2011. ,
DOI : 10.2337/dc10-2411
Analysis of Glucose Responses to Automated Insulin Suspension With Sensor-Augmented Pump Therapy, Diabetes Care, vol.35, issue.7, pp.10-2337, 2012. ,
DOI : 10.2337/dc12-0052
Use of Continuous Glucose Monitoring System in the Management of Severe Hypoglycemia, Diabetes Technology & Therapeutics, vol.11, issue.10, pp.635-639, 2009. ,
DOI : 10.1089/dia.2009.0042
Satisfaction with continuous glucose monitoring in adults and youths with Type???1 diabetes, Diabetic Medicine, vol.12, issue.9, pp.1118-1122, 2011. ,
DOI : 10.1111/j.1464-5491.2011.03368.x
Treatment Satisfaction and Quality of Life for an Integrated Continuous Glucose Monitoring/Insulin Pump System Compared to Self-Monitoring plus an Insulin Pump, Journal of Diabetes Science and Technology, vol.32, issue.8, pp.1402-1410, 2009. ,
DOI : 10.1097/01.MLR.0000062554.74615.4C
Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit, Pediatric Diabetes, vol.7, issue.3, pp.182-187, 2010. ,
DOI : 10.1111/j.1399-5448.2009.00549.x
Psychosocial Correlates of Continuous Glucose Monitoring Use in Youth and Adults with Type 1 Diabetes and Parents of Youth, Diabetes Technology & Therapeutics, vol.14, issue.6, pp.523-526, 2012. ,
DOI : 10.1089/dia.2011.0201
Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial, BMJ, vol.337, issue.sep25 2, p.1680, 2008. ,
DOI : 10.1136/bmj.a1680
Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus, The Journal of Maternal-Fetal & Neonatal Medicine, vol.24, issue.2, pp.256-260, 2003. ,
DOI : 10.1080/jmf.14.4.256.260
Continuous Glucose Monitoring for the Evaluation of Gravid Women With Type 1 Diabetes Mellitus, Obstetrics & Gynecology, vol.101, issue.4, pp.633-638, 2003. ,
DOI : 10.1097/00006250-200304000-00005
Continuous glucose monitoring versus selfmonitoring of blood glucose in the treatment of gestational diabetes mellitus, Diabetes Res. Clin ,
Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes, Diabetes Care, vol.35, issue.1, pp.32-38, 2012. ,
DOI : 10.2337/dc11-1438
perso.univ-rennes1.fr 31. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group, statistiques pour statophobes, pp.1409-1415, 1996. ,
The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes, Diabetes Care, vol.33, issue.6 ,
DOI : 10.2337/dc09-2042
Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes, Cost Effectiveness and Resource Allocation, vol.9, issue.1, p.13, 2011. ,
DOI : 10.2337/diacare.28.3.617
What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care 46, pp.349-356, 2008. ,
Continuous glucose monitoring: coming of age?, European Journal of Endocrinology, vol.166, issue.1, pp.1-4, 2012. ,
DOI : 10.1530/EJE-10-1127
Behavioral and Psychosocial Interventions in Diabetes: A conceptual review, Diabetes Care, vol.30, issue.10, pp.2433-2440, 2007. ,
DOI : 10.2337/dc07-1222
An Algorithm Guiding Patient Responses to Real-Time-Continuous Glucose Monitoring Improves Quality of Life, Diabetes Technology & Therapeutics, vol.13, issue.2, pp.105-109, 2011. ,
DOI : 10.1089/dia.2010.0139
Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator), Pediatr Diabetes, vol.9, pp.142-147, 2008. ,
Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps, Diabetes & Metabolism, vol.37, pp.85-93, 2011. ,
DOI : 10.1016/S1262-3636(11)70972-7
Multinational Study of Subcutaneous Model-Predictive Closed-Loop Control in Type 1 Diabetes Mellitus: Summary of the Results, Journal of Diabetes Science and Technology, vol.2, issue.5, pp.1374-1381, 2010. ,
DOI : 10.1089/dia.2008.0138
Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial, The Lancet, vol.375, issue.9716, pp.743-751, 2010. ,
DOI : 10.1016/S0140-6736(09)61998-X